Botulinum toxin type a for painful limbs moving extremities
β Scribed by Andreas A. Argyriou; Spyridon Papapetropoulos
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 178 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Lerner and Bagic 1 have to be congratulated for their hypothesis on PD pathogenesis. They suggest that the sequence of the brain changes in PD follows specific and repeatable patterns in all cases, as well as that a prion-like process underlies neurodegeneration. These ideas could explain several features of PD, such as the high prevalence of olfactory, autonomic, or sleep abnormalities. However, any pathogenic hypothesis should also explain: *TEMPO, Rasagiline Mesylate [TVP-1012] in Early Monotherapy for Parkinson's Disease Outpatients; PRESTO, Parkinson's Rasagiline: Efficacy and Safety in the Treatment of ''Off.''
π SIMILAR VOLUMES
## Abstract Botulinum toxin is now an established treatment for blepharospasm, hemifacial spasm, spasmodic torticollis, and spastic dysphonia. We report the effectiveness of botulinum toxin against painful limb myoclonus of spinal cord origin. The patient, a 16βyearβold girl with a pulmonary vascul
## Abstract ## Background. Neck dissection surgery is often followed by chronic head and neck pain. To date optimal treatment of this type of pain is lacking. Botulinum toxin type A (BTXβA) has been shown to be effective in the treatment of myofascial pain syndrome and headache. In a pilot study,